Malaria

  • Your Selections:

Refine Results

date

Tags

GHIT Fund Announces New Investments To Develop Drugs, Vaccines, Diagnostics For Malaria, TB, NTDs

Global Health Innovative Technology Fund: GHIT Fund Announces New Investments: A Total of 3.29 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease, Lymphatic Filariasis, and Onchocerciasis, Vaccines for Malaria, and Diagnostics for Leishmaniasis and Mycetoma “The Global Health Innovative Technology (GHIT) Fund announced today a total of 3.29 billion…

NIH Begins Clinical Trial To Evaluate Malaria Drug As Potential Therapy For COVID-19

NIH: NIH clinical trial of hydroxychloroquine, a potential therapy for COVID-19, begins “A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has begun, with the first participants now enrolled in Tennessee. The Outcomes Related to COVID-19 treated…

Novel Coronavirus Pandemic, Trump Freeze On WHO Funding Have Implications For Global Efforts To Prevent, Treat Other Diseases, Including HIV, Polio

AP: Coronavirus could erode global fight against other diseases “…As the world focuses on the [novel coronavirus] pandemic, experts fear losing ground in the long fight against other infectious diseases like AIDS, tuberculosis, and cholera that kill millions every year. Also at risk are decadeslong efforts that allowed the World…

Microbe Found In Mosquitoes Has Potential To Block Malaria Transmission, Study Says

BBC: Malaria ‘completely stopped’ by microbe “Scientists have discovered a microbe that completely protects mosquitoes from being infected with malaria. The team in Kenya and the U.K. say the finding has ‘enormous potential’ to control the disease. … The researchers are now investigating whether they can release infected mosquitoes into…

Blogs, Statements Address Issues Related To COVID-19 Pandemic

BMJ Opinion: Richard Smith: learning from a four-star general on leading in a time of pandemic Richard Smith, former BMJ editor (5/20). Center for Global Development: Why is DFC Investing in Domestic COVID-19 Programs? Clemence Landers, policy fellow, and Prashant Yadav, senior fellow, both with CGD (5/20). Chicago Council on…

Opinion Pieces Discuss Various Aspects Of COVID-19 Pandemic, Including Consequential Effects On Climate Change, Pressure To Quickly Develop Vaccine

Bloomberg: Is the Worst of the Coronavirus Behind Us Now? Lionel Laurent, Bloomberg Opinion columnist (6/1). Devex: A food data revolution in the COVID-19 era Agnes Kalibata, U.N. secretary general’s special envoy for ‘Food Systems Summit 2021’ and president of the Alliance for a Green Revolution in Africa, and Lawrence…

More News In Global Health

AP: First COVID-19, now mosquitoes: Bracing for bug-borne ills (Marcelo, 7/20). Cancer Health: Cancer and HIV Groups Urge Trump Not to Remove U.S. From the WHO (Straube, 7/20). Devex: U.N. forum offers ‘sobering’ vision of SDGs progress and new virtual reality (Lieberman, 7/21). Scientific American: Genes May Influence COVID-19 Risk,…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.